Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines

Journal of Hepatology

Volumn 25, Issue 4, 1996, Pages 454-464

  Yano, Hirohisa ^a   Fukuda, Kazunori ^b   Haramaki, Makoto ^a   Momosaki, Seiya ^a   Ogasawara, Sachiko ^a   Higaki, Koichi ^a   Kojiro, Masamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

APO 1; Apoptosis; Cell line; Fas; Hepatocellular carcinoma; Interferon

Indexed keywords

ANTIBODY; DNA FRAGMENT; FAS ANTIGEN; MESSENGER RNA;

AGAR GEL ELECTROPHORESIS; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL DEATH; CELL VIABILITY; CULTURE MEDIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0030273335     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80204-2     Document Type: Article

References (29)

1. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 68:1980;251-306.
2. Jfr Kerr, Harmon BV. Definition and incidence of apoptosis: an historical perspective. Tomei LD, Cope FO. Apoptosis: the Molecular Basis of Cell Death. 1991;5-29 Cold Spring Harbor Laboratory Press, New York.
3. Wong GHW, Goeddel DV. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol. 152:1994;1751-1755.
4. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 169:1989;1747-1756.
5. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
6. Morimoto H, Yonehara S, Bonavida B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 53:1993;2591-2596.
7. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bc1-2 are not predictive of biological responsiveness. Cancer Res. 54:1994;1580-1586.
8. Trauth BC, Klas C, Peters AMJ, Matzuku S, Möller P, Falk W, Debatin K-M, Krammer PH. Monoclonal antibody-medicated tumor regression by induction of apoptosis. Science. 245:1989;301-305.
9. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily-sequence identity with the Fas antigen. J Biol Chem. 267:1992;10709-10715.
10. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today. 16:1995;39-43.
11. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med. 179:1994;873-879.
12. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
13. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH, Möller P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest. 69:1993;415-429.
14. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314-317.
15. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature. 364:1993;806-809.
16. Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C, Levrero M. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene. 11:1995;1157-1164.
17. Yano H, Iemura A, Fukuda K, Mizoguchi A, Haramaki M, Kojiro M. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells. Hepatology. 18:1993;320-327.
18. Murakami T. Establishment and characterization of human hepatoma cell line (KIM-1). Acta Hepatol Jap. 25:1984;532-539.
19. Yano H, Kojiro M, Nakashima T. A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma. In Vitro Cell Dev Biol. 22:1986;637-646.
20. Yano H, Maruiwa M, Murakami T, Fukuda K, Ito Y, Sugihara S, Kojiro M. A new human pleomorphic hepatocellular carcinoma cell line, KYN-2. Acta Pathol Jpn. 38:1988;953-966.
21. Murakami T, Maruiwa M, Fukuda K, Kojiro M, Tanaka M, Tanikawa K. Characterization of a new human hepatoma cell line (KYN-3) derived from the ascites of the hepatoma patient (Abstract). Jpn J Cancer Res. 1988;292 Proceedings of the Japanese Cancer Association.
22. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
23. Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M. Expression of CD44 in human hepatocellular carcinoma cell lines. Hepatology. 21:1995;1276-1284.
24. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries-association of acidic FGF with plaque microvessels and macrophages. J Clin Invest. 92:1993;2408-2418.
25. Richards GM. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem. 57:1974;369-376.
26. 1 phase. Cancer Res. 54:1994;448-454.
27. Itoh N, Tsujimoto Y, Nagata S. Effect of bc1-2 on Fas antigen-mediated cell death. J Immunol. 151:1993;621-627.
28. Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood. 83:1994;1856-1861.
29. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood. 84:1994;1201-1208.